Thu, Apr 17, 2014, 2:05 AM EDT - U.S. Markets open in 7 hrs 25 mins


% | $
Quotes you view appear here for quick access.

Cadence Pharmaceuticals Inc. Message Board

  • green_bar_spike green_bar_spike Aug 14, 2013 4:03 PM Flag

    Drop a Puzzle

    This drop in CADX is a real puzzle. There is nothing in terms of financials or other news that might explain a move from around $8 to $5.74 since July 24. But, the stock is drifting down on low volume and, obviously, with the drop, some stockholders are getting discouraged and selling out. At some point, if there is still no negative news, the selling will be exhausted and the uptrend should resume. But, if that is to happen, I'd like to see heavier volume on the downside. At least that is the way I see it.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • CADX made a comeback from a low of $5.43 today and the volume was slightly above average. It had been going down on low volume. I had been hoping the volume would be greater on the downside to flush out almost all the weak hands, but I will take what I can get. Let us hope today was the turning point for CADX.

      Sentiment: Strong Buy

    • No catalyst till next ER and/or court decision......

    • Well that might have been the goal here---there was a decent short interest and the whole thing may be for covering purposes. maybe check out short interest changes over the last 6 months---maybe we will see a smaller short level than in the past? I see nothing in the fundamentals---why dilute off 30% reduction in the PPS, to buy another compound or company?

      My guess is short covering or driving it down for a later deal or buyout cheapen the cost. I am glad I added three times to my position. I will do it again if they continue this!

      Look at what the sales numbers portray---moving to cash flow positive with growth still to build in! After all this time ramping up what not to like and why is there even negative sentiment in this much at all. xela isn;t going to win anything but some small payday and if the judge rules their way CaADX will just request an appeal. Exela cant make this stuff given the chemistry!



      Sentiment: Strong Buy

      • 2 Replies to sphericalkutz
      • Kutz,

        I'm just a finance guy so I'm looking at the sales, gross margins, etc. I would have thought there would have been a mention of sales for July at the conference the other day. Thought that would have been a catalyst for a move. Clearly these guys don't know how to communicate with either their shareholder base or the analysts who cover the stock. Unfortuante.

        Additionally, the hopefully temporary glitch in sales could have been caused by accounting problems in reporting sales. These guys are certainly not the creme de la creme of management.

        I'm not really worried about Excela because no one else has been able to produce Ofirmev which is telling. Perrigo wouldn't have entered into a manufacturing agreement with Cadence if they could have gotten it cheaper elsewhere.



      • Two things have adversly effected the stock. One is the earnings miss on the loss side. Ted goes and presents at these Conferences and than he misses by 5 cents on the loss side. Wallstreet hates to be blindsided. Ted needs to manage expectations better, since he is presenting to f*cking morons.
        The other issue was the FDA posted that they were seeing some adverse reactions in patients taking acetaminophen.. This is not related to Ofirmev, but to all doses of acetaminophen. This drug has been out for over 60 years and this side effect has been know about all these years. They see a higher incidence during this period and it becomes news worthy. No one has died from the side effect.
        This company at these stock prices is making it a takeover candidate.. I see mid teens, but I feel the stock in 12-18 months will be over $20.

13.980.00(0.00%)Mar 18 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.